baber/WOPTO huggingface dataset:
Patent NZ-293008-A (NZ)
Title: Photoactivatable compound-carrier molecule conjugates for transfer into a cell cytosol where they are taken up by endosomes and lysosomes
Inventor: BERG KRISTIAN
IPC: A61K41/00
Filed: 1995-09-04
Abstract: A composition for the modification of neoplastic and other cellular process in warm blooded animals or cell cultures is described.  The composition contains a membrane impermeable compound to be released selected from the group containing DNA, oligo (deoxy) nucleotides, mRNA, antisense DNA, sugars, proteins, peptides, membrane impermeable drugs, other membrane impermeable molecules, covalently or non-covalently bonded combinations from the above mentioned molecules, gelonin (an antineoplastic compound) and a photosensitizing compound selected from the a group containing porphyrins, phthalocyanines, purpurins, chlorines, benzoporphyrins, napthalocyanines, cationic dyes, tetra cyclones and lysosomotrophic weak bases and derivates thereof.  The composition is taken up in endosomes, lysosomes or other cell compartments. Light activation of photosensitizing compound is then used to rupture the membranes of the endosomes, lysosomes or other cell compartments, releasing the molecules into the cytosol of cells.
Patent NZ-307023-A (NZ)
Title: -piperidin-1-yl-2-(2-pyIsothiazolones such as 2-(6-methoxy-3-oxo-3h-benzo[d]isothiazol-2yl)-pentanoic acid; 6-piperidin-1-yl-2-(2-pyridin-2-yl-ethyl)-isothiazolo[5,4-d]pyrimidin-3-one for treating inflammation, retroviral or atherosclerosis
Inventor: BOLTON GARY LOUIS
IPC: A61K31/519
Filed: 1996-04-26
Abstract: Isothiazolones having the general structure as shown useful as anti-retroviral agents, anti-inflammatory agents, and anti-atherosclerotic agents. Wherein; A is a monocyclic ring having 5 or 6 ring atoms, or a bicyclic ring having from 9 to 12 ring atoms, the ring atoms being selected from carbon and optionally up to 3 heteroatoms selected from 0, S, and N; R1 and R2 independently are hydrogen, halo, C1-6alkyl, C3-6cycloalkyl, Het(CR6R7)m-, phenyl-(CR6R7)m-, O-C1-6alkyl, hydroxy, nitro, cyano, NR3R4, NR3COR4, CO2R3, CONR3R4, S(O)mR3, SO3H, S(O)mNR3R4, COR3, or taken together are oxo(O=) or methylene dioxy (-O-CH2-O-); m is 0, 1 or 2; R3 and R4 independently are hydrogen, C1-6alkyl, C3-6cycloalkyl, Het(CR6R7)m-, or phenyl-(CR6R7)m-;   R6 and R7 independently are hydrogen, C1-6alkyl, CO2R3, hydroxy, CONR3R4, or cyano; R5 is C1-6alkyl, COC1-6alkyl, or C3-6cycloalkyl; and wherein the foregoing alkyl, CO alkyl and cycloalkyl are substituted with at least one group selected from NR3COR4, CO2R3, CONR3R4, S(O)3H, S(O)mNR3R4 and COR3, where m, R3 and R4 are as defined above.
Patent NZ-332545-A (NZ)
Inventor: GEERTS HUGO ALFONS GABRIEL
IPC: A61P35/04
Filed: 1997-05-26
Abstract: he present invention relates to a compound 1-(1H-pyrrol-2-ylmethyl)-2-piperidone of the formula 1 for use as a medicament where the disease is metastasis, and the process for preparing this as a pharmaceutical composition.
Patent NZ-334136-A (NZ)
Title: Method and device for recording information on a carrier
Inventor: MIMNAGH WINSLOW MICHAEL
IPC: G11B20/18
Filed: 1998-05-25
Abstract: method of digitally recording information on a suitable medium, particularly a CD is described, in which method a recording (11) is made during a recording session.  The recording (11) comprises a program portion (20) with the information to be recorded.  Prior to recording the program portion (20), a predetermined number of run-in blocks (21, 22, 23, 24) is recorded, and subsequent to recording the program portion (20), a predetermined number of run-out blocks (25, 26) is recorded.  During the recording session, an identification code (RID) identifying the recording apparatus used for the relevant recording session is recorded on the medium.  In accordance with the present invention, this identification code (RID) is recorded in at least one of said run-in blocks (21, 22, 23, 24) and run-out blocks (25, 26).  This provides the possibility of recording a full identification code, even in the case of relatively short recordings.
Patent NZ-500511-A (NZ)
Title: Reclosable fastener assembly with slider having separating leg penetrating at least one of uppermost interengaging closure elements but not penetrating bottom closure elements, with abrupt narrowing effect
Inventor: PORCHIA JOSE
IPC: A44B19/36
Filed: 1998-04-24
Abstract: Reclosable fastener strips 14,15 have upper and lower inter-engaging closure elements 16a/17a, 16b/17b. Slider 10 passes between upper elements but not lower elements with an abrupt narrowing effect. This is directed at preventing leakage from bags having such fasteners.
Patent NZ-503339-A (NZ)
Title: Carboxamidothiazole derivatives for treating cholecystokinin CCK-A receptor mediated diseases
Inventor: MOLIMARD JEAN-CHARLES
IPC: A61P1/06
Filed: 1998-09-18
Abstract: Compounds of formula (I)b wherein: R6a is chlorine or methyl, R10, R11 and R13 are, independently of each other, hydrogen, a methyl, ethyl, hydroxyl, acetyloxy, methoxy, ethoxy, methylthio, trifluoromethyl, an amino group or a halogen, with the limitation that one or two of the substituents R10, R11 and R13 is a group other than hydrogen. These thiazole compounds are useful as cholecystokinin (CCK) agonists.
Patent NZ-509820-A (NZ)
Title: Large round baler with side walls moving horizontally relative to chassis, and upper baling chamber front and rear sections hinged
Inventor: VIAUD JEAN
IPC: A01F15/07
Filed: 2001-02-12
Abstract: A baler for making large cylindrical bales, the baler including a mobile chassis supporting opposite side walls which cooperate with a bale-forming arrangement to define front and rear baling chambers, the bale-forming arrangement including lower and upper baling chamber sections, the upper baling chamber section being subdivided into front and rear chamber wall portions that are mounted to the chassis for swinging vertically between a lowered working position, the front and rear chamber wall portions cooperate with the lower chamber section to enclose and form a cylindrical bale, and a raised non-working position, wherein the baling chambers are opened; the upper baling chamber section being mounted to said side walls; and the side walls being mounted to the chassis for horizontal movement relative to the lower chamber section.
Patent NZ-510222-A (NZ)
Title: Liquid filter with manifold distributor at inlet to direct liquid in two or more opposite directions
Inventor: SCHEWITZ JONATHAN
IPC: B01D29/15
Filed: 2001-02-26
Abstract: Liquid flows into the container 1 via inlet 7 which has at least two outlets (12 or 13 reflecting two respective separate embodiments). This is stated to reduce wear on filter bags 5. Filtration aid (such as diatomaceous earth) and dirt fall into container 1 during no flow through inlet 7. On start-up, during a subsequent cycle, inlet liquid is stated to be directed in advantageous directions.
Patent NZ-511558-A (NZ)
Title: Method and arrangement for the continuous production of lignocellulose-containing boards, with gas emission and steam captured and hot air supplied to take mixture to combustion chamber
Inventor: LUNDGREN GORAN
IPC: B27N3/24
Filed: 1999-11-01
Abstract: Disclosed is a method and an arrangement for the continuous production of lignocellulosic boards, wherein material is disintegrated into particles and/or fibres, glued, dried and formed into a mat (1). The mat is pressed in a continuous steam- injection press (2) into board form (3) and then passed through an after-conditioning unit (4). Gaseous emissions and steam occurring in the press process are captured. Hot air is supplied to prevent condensation of the gaseous emissions and the steam when leakage air from the surroundings is admixed therewith and also to transport the steam and emissions to a combustion plant for combustion.
Patent NZ-514229-A (NZ)
Title: Method and composition for controlling lice
Inventor: KUSSENDRAGER KLAAS DANIEL
IPC: A01N63/50
Filed: 2000-03-23
Abstract: A method for controlling lice on an organism, comprising of treating the organism with a composition at least consisting of: a) lactoperoxidase; b) thiocyanate; and/or c) iodide; and d) a hydrogen peroxide source; and a composition and kit for use in the method is disclosed. The method is particularly suitable for controlling sea lice in fish or crustaceans, but can also be applied against aphids on plants and head lice on humans.
Patent NZ-516568-A (NZ)
Title: Self-contained container ship
Inventor: LE COZ DANIEL
IPC: B63B15/02
Filed: 2001-04-26
Abstract: A container ship 1 suitable for open ocean or shallow river work and not dependent for operation on the provision of onshore container handling facilities, includes a portal crane 3 moving on rails on either side of the container hold(s) 2 and stowable in an area of the hold. If the crane is not stowed in the hold then containers may be stowed in the vacant area.  For river and bridge work the ballast may be shed from between the double bottom tanks and the ship's bridge 4 and superstructure may be retracted into the hold.  For ocean work, the holds may be provided with watertight hatch covers, ballast may be taken on board, containers can be stacked on top of the watertight hatch covers, and the ship's bridge and superstructure may be elevated.
Patent NZ-516792-A (NZ)
Title: Combination therapy using a sodium/hydrogen exchange type 1 inhibitor and a second agent for reducing tissue damage resulting from ischemica
Inventor: TRACEY WAYNE ROSS
IPC: A61K31/336
Filed: 2002-01-24
Abstract: A  pharmaceutical  composition,  useful  for  reducing tissue  damage resulting from ischemica, comprises a sodium- hydrogen exchanger type-1 inhibitor and either: (a) a complement modulator, (b) a metabolic modulator, (c) an anti-apoptotic agent, (d) a nitric oxide synthase-related agent, or (e) an enzyme/protein modulator The sodium-hydrogen exchanger type-1 inhibitor is (i)   a  compound  of  formula  (I)  or  a  prodrug   or   a pharmaceutically acceptable salt thereof wherein Z is carbon connected  optionally  mono-, di-, or tri-substituted  five- membered,  diaza,  or triaza di-unsaturated  ring  with  the diaza ring having two contiguous nitrogens; (ii)  cariporide,  or  a  pharmaceutically  acceptable  salt thereof; (iii)  eniporide,  or  a  pharmaceutically  acceptable  salt thereof; (iv)   BIIB  513,  or  a  pharmaceutically  acceptable  salt thereof; (v) TY-12533, or a pharmaceutically acceptable salt thereof; or (vi)   SM-15681,  or  a  pharmaceutically  acceptable   salt thereof. The  complement  modulator  is a C5a  inhibitor,  a  soluble complement receptor type 1 (sCR1) inhibitor or a C1-esterase inhibitor. The  metabolic modulator is a pyruvate dehydrogenase complex up-regulator/activator,  a  pyruvate  dehydrogenase   kinase inhibitor, a malonyl CoA decarboxylase inhibitor, an  acetyl CoA  carboxylase activator, a partial fatty  acid  oxidation (pFOX)  inhibitor, a 5' AMP-activated protein kinase  (AMPK) inhibitor, a carnitine palmitoyl transferase inhibitor, or a fatty acid CoA synthase inhibitor. The anti-apoptotic agent is a caspase inhibitor. The  nitric  oxide  synthase-related agent is  monophosporyl lipid  A, or an analog thereof, a nitric oxide donor,  or  a nitric oxide synthase activator. The   enzyme/protein  modulator  is  a  protein   kinase   C activator,  an  endothelin converting  enzyme  inhibitor,  a tissue-activated fibrinolytic inhibitor (TAFI), a  Na+/Ca2+- exchanger  isoform-1  (NCX-1)  inhibitor,  or  a  poly  (ADP ribose) synthetase (PARS/PARP) inhibitor.
Patent NZ-516815-A (NZ)
Title: Object imaging system
Inventor: MALMSTROM KURT
IPC: G03B15/07
Filed: 2000-07-10
Abstract: An object imaging system, particularly for slaughtered animal carcases or meat pieces, includes an imaging station to which the object (10) is introduced, a camera (20) at the imaging station, and lighting means (30). The imaging station includes a backing member (15) for providing a background for the object (10), and an image capture enclosure (21) which has an open side (22) facing towards the backing member (15), the inside surfaces of the enclosure (21) being non-reflective. The camera (20) is mounted in the enclosure (21) and faces towards the open side (22) and towards the backing member (15). The lighting means (30) includes multiple light sources (31), some of the light sources (35, 36, 37) being provided inside the image capture enclosure (21) and located so as to face towards the open side (22) thereof and some of the light sources (32, 33, 34) being provided outside the enclosure to face towards the backing member (15), the light sources (31) being located at points which define an imaginary concave surface (38) with the concavity facing towards and being generally focussed on a region where the object (10) is introduced for imaging. The camera (20) has an associated camera housing (40) completely enclosing the camera in a sealed environment, the housing (40) having an associated temperature control means (45) operative to maintain a predetermined temperature or temperature range for the camera (20).
Patent NZ-517046-A (NZ)
Title: Kit for chondrocyte cell transplantation
Inventor: GIANNETTI BRUNO
IPC: A61F2/30
Filed: 2000-08-02
Abstract: A use of chondrocytes and an absorbable covering cap in the manufacture of a medicament for the effective treatment of articulating joint surface cartilage formulated for sequential application of said chondrocytes and cap to a surface to be treated after cartilage as first been removed from said surface and wherein the covering cap is formed of one or more proteins with the proviso that the cap is not formed exclusively of collagen.
Patent NZ-518022-A (NZ)
Title: Analysis and diagnosis by intelligent processing of remotely generated genetic hybridization profiles
Inventor: OSBORNE GLENN F
IPC: G16B25/00
Filed: 2000-08-28
Abstract: A system for the analysis of nucleic acid array hybridization information, comprising: a user facility, and a central data processing facility comprising: (i) a Web server that communicates with at least one user facility, receiving and transmitting hybridization information, supporting data analyses, and providing security and business functions, (ii) a database server that stores hybridization profiles, clinical information associated with hybridization profiles, and statistical information associated with hybridization profiles; and (iii) an application server that facilitates information exchange between the Web server and the database server and comprising database query for chip ID genetic pattern, database query for statistical data summary, pattern match statistical processing and results output functions; said Web server, said database server, and said application server are functionally connected together, said system is configured to receive, store and analyze nucleic acid array hybridization data and comprising a set of rules for comparing said nucleic acid array hybridization data to hybridization data stored in an updatable database having access to all input hybridization results, and comprising a set of rules linking hybridization data profiles with associated diagnosed conditions and treatment options to determine a physiological condition suggested by said analyzed data.
Patent NZ-518647-A (NZ)
Title: Gaming console and system having dynamic feature game
Inventor: BENNETT NICHOLAS LUKE
IPC: A63F13/00
Filed: 2000-09-29
Abstract: A gaming console or system including a video display, and a game control processor arranged to control images displayed on the video display. The console or system is characterised in that the game control processor includes a dynamic game feature whereby a feature game 40 occurs upon a first trigger condition of the first game 30, and wherein a second trigger condition influences one or more gameplay aspects of the feature game such as to alter the likelihood of occurrence of at least one possible outcome of a set of possible outcomes of the feature "spinning wheel" game. In the drawing, the symbol 'K' 32 constitutes the first trigger condition that begins the feature game 40. Assuming a $100 note image was displayed in column 34, this would cause one of the sectors 42 of the feature game to change from a blank space to a $100 prize. The $100 note image on the main game 30 is the second trigger condition, this condition clearly affecting the outcome in the feature game.
Patent NZ-526705-A (NZ)
Title: Amphibious vehicle
Inventor: BRYHAM MAURICE JOHN
IPC: B60F3/00
Filed: 2002-12-27
Abstract: An amphibious vehicle (1), in the form of an inflatable boat (2) has a self-propelled and steerable retractable undercarriage system, enabling the vehicle to enter and exit the water under its own power. The swing of the wheels and their supporting struts (3) & (4) occurs external to the hull of the vehicle. A steerable nose leg (3) is raised or lowered by an actuator situated inside the boat. Stowage is accomplished within the lines of an inflatable craft by the incorporation of fibreglass fairings (5) & (6) sized to match the main inflated tubes (7). Power is provided to the back wheels (4) via an internal drive train within the legs (4). All terrain balloon type tyres are used to enable the boat to travel over a variety of shoreline terrain. A steering system engages with the front wheel when the wheel is in its extended position. Motive power is provided by a separate air-cooled motor.
Patent NZ-530440-A (NZ)
Title: Compounds containing zinc and a phenolic antioxidant for topical application to reduce and/or prevent lesions associated with viral infections
Inventor: SMITH JEFFREY B
IPC: A61K31/60
Filed: 2002-06-04
Abstract: One aspect relates to anti-viral composition containing at least one zinc compound and at least one phenolic antioxidant (and optionally other ingredients such as at least one analgesic, at least one hydrocarbyl containing compound, and water). Another aspect relates to a method of treating lesionous symptoms of a viral infection involving applying an effective amount of the zinc containing anti-viral composition to the lesions. Use of at least one zinc compound, at least one phenolic antioxidant, at least one hydrocarbyl containing compound, and water in the preparation of a medicament for the treatment of lesionous symptoms of a viral infection in a patient in need thereof, wherein the medicament comprises: about 0.005% by weight or more and about 20% by weight or less of the at least one zinc compound; about 0.001% by weight or more and about 20% by weight or less of the at least one phenolic antioxidant; about 5% by weight or more and about 80% by weight or less of the at least one hydrocarbyl containing compound; and about 0.1% by weight or more and about 60% by weight or less of the water.
Patent NZ-532766-A (NZ)
Title: Weather protection device for the protection of special plant cultures sensitive to moisture
Inventor: VOHRINGER REINHARD
IPC: A01G13/02
Filed: 2002-10-30
Abstract: Disclosed is a low-cost weather protection device for the protection of special plant cultures (4) which are sensitive to moisture and sunlight, comprising at least one substantially waterproof protective skin (2, 3) which is fixed to a carrier unit (1, 8, and 11) and offers simple, effective protection of plants in particular against the effects of the weather even over long time periods and for large-surface applications. The protective skin is fixed on the carrier unit in such a way that it is partially pivotable, being able to swing out of a rest position due to the effect of wind energy, and at least one net (9), and/or meshwork is provided, on which the protective skin lies.
Patent NZ-532770-A (NZ)
Title: Sulfonamido substituted imidazopyridines for use as immunomodulators inducing cytokine biosynthesis
Inventor: DELLARIA JOSEPH FRED
IPC: A61P25/00
Filed: 2002-06-07
Abstract: Disclosed is a compound of formula (I) wherein X is alkylene of alkenylene, Y is SO2, Z is a bond or ?NR6- and R1-6 are as defined in the specification. Pharmaceutical compositions of this type are useful for inducing cytokine biosynthesis in an animal, treating viral disease in an animal and treating neoplastic disease in an animal.
Patent NZ-533082-A (NZ)
Title: Enhanced herbicide composition
Inventor: SILVERMAN F PAUL
IPC: A01N41/06
Filed: 2002-11-26
Abstract: Provided is a composition when used as a herbicide, comprising a protoporphyrinogen oxidase inhibitor and salicylate or another SAR inducer or a combination thereof, wherein the protoporphyrinogen oxidase inhibitor is selected from the group consisting of lactofen and flumioxazin. Further provided are said compositions with specified percentages of components and methods of controlling plant growth with said compositions.
Patent NZ-534058-A (NZ)
Title: DSP assisted peak capture circuit and method
Inventor: LOEWE THOMAS D
IPC: G01R19/04
Filed: 2003-01-31
Abstract: Peak capture circuitry and method for measuring a peak value of a waveform are disclosed. The waveform is characterized by having a first portion with a first rate of change and a second portion with a relatively faster rate of change. Peak stretching circuitry stretches a portion of the waveform as a function of time. Digital signal processing circuitry samples an output waveform of the peak stretching circuitry for determining the peak value. Despite any steeply sloped portion, samples can be reliably taken throughout the waveform for calculation of peak value.
Patent NZ-536488-A (NZ)
Title: Polymorphic forms of phenyl oxazolidinone derivatives
Inventor: DAS BISWAJIT
IPC: C07D413/14
Filed: 2003-05-15
Abstract: Polymorphic forms of phenyl oxazolidinone derivatives are disclosed. Particularly disclosed are polymorphic forms of (S)-N-[[3-fluoro-4-[N-1[4-{2-furyl-(5-nitro)methyl}]piperazinyl]-phenyl]-2-oxo-5-oxazolidinyl]-methyl]acetamide hydrochloride having the X-ray powder diffraction peaks as described in the specification and shown in the drawings. These compounds are suitable for use as antimicrobials, pharmaceutical compositions containing these polymorphic forms, and processes for the preparation of the polymorphic forms are also disclosed.
Patent NZ-536564-A (NZ)
Title: Vascularization enhanced graft constructs which comprise a matrix composition consisting of liver basement membrane
Inventor: BADYLAK STEPHEN FRANCIS
IPC: A61K35/34
Filed: 2003-05-01
Abstract: A tissue graft construct for use in repairing diseased or damaged tissues is provided. The tissue graft construct comprises a matrix composition selected from the group consisting of liver basement membrane and extracts and hydrolysates thereof, and added endothelial cells, and at least one additional preselected, exogenous population of cells which are involved in the initiation of vessel-like structures in the graft. The preselected population of cells can be a population of non-keratinized or keratinized epithelial cells.
Patent NZ-537474-A (NZ)
Title: Blister protection for spirally wound elements of semipermeable membrane sheet material
Inventor: DE LA CRUZ DEBORAH
IPC: B01D65/00
Filed: 2003-06-20
Abstract: A method for preventing osmotic blistering in spirally-wound elements of semipermeable membrane sheet material in locations otherwise subject thereto is disclosed, wherein the method comprises the step of: applying a sealant to the upstream surface of the membrane sheet material in locations where the downstream surface thereof has been so treated that flow there-through is prevented, which sealant prevents liquid from permeating into the membrane in such regions and potentially resulting in osmotic blistering.
Patent NZ-538519-A (NZ)
Title: Bicifadine formulation for reducing pain
Inventor: CODD JANET
IPC: A61K31/403
Filed: 2003-07-21
Abstract: Disclosed is a use of a bicifadine compound of the formula (I) and a pharmaceutically acceptable salt thereof, for the preparation of a medicament in a unit oral dosage form for reducing pain, the dosage form comprising from about 25 to 600 mg. of the compound and a pharmaceutically acceptable carrier in an amount of from about 40% to 60% of weight of said composition, and from about 15% to 50% by weight of said composition of a hydroxypropyl methyl cellulose hydrophilic slow release polymer matrix.